Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 2/20 | 0.75 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.75 |
| ▸ | GRM8 | O00222 | 2/20 | 0.75 |
| ▸ | GRM6 | O15303 | 2/20 | 0.75 |
| ▸ | GRM7 | Q14831 | 2/20 | 0.75 |
| ▸ | GRM4 | Q14833 | 2/20 | 0.75 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.75 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.75 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.75 |
| ▸ | GRM5 | P41594 | 1/20 | 0.75 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.75 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.75 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.75 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.75 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.75 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.75 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.75 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.75 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.75 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.75 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| D-Glutamate SCHEMBL4414452 | 1.00 | GSR (0.75) | GSRCYP1A2GRM8GRM6GRM7 | |
| D-Glutamate SCHEMBL6850403 | 1.00 | GSR (0.75) | GSRCYP1A2GRM8GRM6GRM7 | |
| Glutamic Acid SCHEMBL6850406 | 1.00 | GSR (0.75) | GSRCYP1A2GRM8GRM6GRM7 | |
| D-Glutamate SCHEMBL11310231 | 1.00 | GSR (0.75) | GSRCYP1A2GRM8GRM6GRM7 | |
| D-Glutamate SCHEMBL8506699 | 0.96 | GSR (0.69) | GSRCYP1A2GRM8GRM6GRM7 | |
| Glutamic Acid SCHEMBL8506700 | 0.96 | GSR (0.69) | GSRCYP1A2GRM8GRM6GRM7 | |
| Lysine SCHEMBL205003 | 0.94 | GSR (0.80) | GSRCYP1A2GRM8GRM6GRM7 | |
| D-Glutamate SCHEMBL21796040 | 0.94 | GSR (0.80) | GSRCYP1A2GRM8GRM6GRM7 | |
| Lysine SCHEMBL890044 | 0.94 | GSR (0.80) | GSRCYP1A2GRM8GRM6GRM7 | |
| Lysine SCHEMBL1079952 | 0.94 | GSR (0.80) | GSRCYP1A2GRM8GRM6GRM7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1044672-B1 | Water-in-oil emulsified cosmetic | SHISEIDO CO LTD (JP) | 2007-03-07 | — | — | EP | claimed |
| CN-115976028-B | Glycogen disease type Ia therapeutic agent | 第一三共株式会社 | 2025-03-25 | — | — | CN | disclosed |
| EP-3431605-B1 | PUTRESCINE-PRODUCING MICROORGANISM AND METHOD FOR PRODUCING PUTRESCINE USING SAME | CJ CHEILJEDANG CORP (KR) | 2024-11-06 | — | — | EP | disclosed |
| CN-118272259-A | Strain for fermenting bean dregs into fermentation liquor and application thereof | 江西师范大学 | 2024-07-02 | — | — | CN | disclosed |
| EP-2492301-B1 | NOVEL CO-MODIFIED ORGANOPOLYSILOXANE | DOW TORAY CO LTD (JP) | 2023-03-29 | — | — | EP | disclosed |
| US-20220168383-A1 | NEUROTENSINERGIC AGONISTS AND METHODS OF USING SAME PREVENTING OR TREATING PAIN | SOCPRA SCIENCES SANTÉ ET HUMAINES S.E.C. (CA) | 2022-06-02 | — | — | US | disclosed |
| EP-3921331-A1 | NEUROTENSINERGIC AGONISTS AND METHODS OF USING SAME PREVENTING OR TREATING PAIN | Socpra Sciences Santé Et Humaines S.E.C. (CA) | 2021-12-15 | — | — | EP | disclosed |
| US-11124812-B2 | Putrescine-producing microorganism and method for producing putrescine using the same | CJ CHEILJEDANG CORPORATION (KR) | 2021-09-21 | — | — | US | disclosed |
| WO-2020160685-A1 | NEUROTENSINERGIC AGONISTS AND METHODS OF USING SAME PREVENTING OR TREATING PAIN | SOCPRA Sciences Sante et Humaines S.E.C. (CA) | 2020-08-13 | — | — | WO | disclosed |
| CN-106459888-B | Microorganism for producing putrescine and method for producing putrescine using the same | CJ第一制糖株式会社 | 2019-12-24 | — | — | CN | disclosed |
| US-6210690-B1 | SPECIFIC POLYETHER MODIFIED SILICONE, WATER OR WATER AND ETHYL ALCOHOL AS WELL AS A WATER SOLUBLE POLYMER WITH A MOLECULAR WEIGHT OF 2,000-300,000, AN INORGANIC SALT OR AMINO ACID SALT | SHISEIDO COMPANY, LTD. (JP) | 2001-04-03 | — | — | US | disclosed |
| EP-1077692-A1 | AMINO ACID STABILIZED GABAPENTIN AND PREGABALIN PREPARATIONS AND PROCESS FOR PREPARING THE SAME | Warner-Lambert Company LLC (US) | 2001-02-28 | — | — | EP | disclosed |
| EP-1044672-A1 | Water-in-oil emulsified cosmetic | SHISEIDO COMPANY LIMITED (JP) | 2000-10-18 | — | — | EP | disclosed |
| WO-1999059573-A1 | STABILIZED PHARMACEUTICAL PREPARATIONS OF GAMMA-AMINOBUTYRIC ACID DERIVATIVES AND PROCESS FOR PREPARING THE SAME | WARNER-LAMBERT COMPANY (US) | 1999-11-25 | — | — | WO | disclosed |
| CN-1219119-A | Emulsion composition | SHISEIDO CO LTD (JP) | 1999-06-09 | — | — | CN | disclosed |
| EP-0914814-A1 | EMULSION COMPOSITION | SHISEIDO COMPANY LIMITED (JP) | 1999-05-12 | — | — | EP | disclosed |
| EP-0081236-B1 | A COMPOUND SEASONING COMPOSITION, A PROCESS FOR ITS PRODUCTION AND ITS USE AS A FOOD COMPONENT | AJINOMOTO CO., INC. (JP) | 1986-04-23 | — | — | EP | disclosed |
| US-4563359-A | MIXTURE OF GLUTAMIC ACID WITH SODIUM AND POTASSIUM SALTS | AJINOMOTO COMPANY, LIMITED (JP) | 1986-01-07 | — | — | US | disclosed |
| EP-0081236-A1 | A compound seasoning composition, a process for its production and its use as a food component | AJINOMOTO CO., INC. (JP) | 1983-06-15 | — | — | EP | disclosed |
| US-4273684-A | Transparent detergent bar | AJINOMOTO CO., INC. (JP) | 1981-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220168383-A1 | NEUROTENSINERGIC AGONISTS AND METHODS OF USING SAME PREVENTING OR TREATING PAIN | VIP, NTSR2, VIPR2 | GSR 670/4885CYP1A2 1382/4885GRM8 644/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.